- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case F-58/14: Judgment of the Civil Service Tribunal (Second Chamber) of 17 February 2016 — DE v EMA (Civil service — Temporary staff member — Non-renewal of a fixed-term contract — First paragraph of Article 8 of the CEOS — Material change in the nature of the duties performed by the staff member — Interruption of the career path — Reclassification of a fixed-term contract as a contract of indefinite duration — Excluded)
ECLI:EU:UNKNOWN:62014FA0058
62014FA0058
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
29.3.2016
Official Journal of the European Union
C 111/43
(Case F-58/14) (<span class="super">1</span>)
((Civil service - Temporary staff member - Non-renewal of a fixed-term contract - First paragraph of Article 8 of the CEOS - Material change in the nature of the duties performed by the staff member - Interruption of the career path - Reclassification of a fixed-term contract as a contract of indefinite duration - Excluded))
(2016/C 111/52)
Language of the case: English
Parties
Applicant: DE (represented by: S. Rodrigues and A. Blot, lawyers)
Defendant: European Medicines Agency (EMA) (represented initially by S. Marino, T. Jabłoński and N. Rampal Olmedo, acting as Agents, assisted by D. Waelbroeck and A. Duron, lawyers, and subsequently by S. Marino, T. Jabłoński, F. Cooney and N. Rampal Olmedo, acting as Agents, assisted by D. Waelbroeck and A. Duron, lawyers)
Re:
Application for annulment of the decision not to renew the applicant’s temporary staff contract, and a claim for compensation for the damage which the applicant claims to have suffered.
Operative part of the judgment
The Tribunal:
1.Dismisses the action;
2.Orders DE to bear his own costs and to pay the costs incurred by the European Medicines Agency.
(<span class="note"> <a id="ntr1-C_2016111EN.01004301-E0001" href="#ntc1-C_2016111EN.01004301-E0001">*1</a> </span>) OJ C 292, 1.9.2014, p. 63.